헤파린 시장 규모, 점유율, 성장 분석 : 제품 유형별, 투여 방법별, 공급원별, 상태별, 제품별, 치료법별, 유통 채널별, 용도별, 최종사용자별, 지역별 - 산업 예측(2025-2032년)
Heparin Market Size, Share, and Growth Analysis, By Product Type, By Mode of Administration, By Source, By Ingredient, By Availability, By Treatment, By Distribution Channel, By Application, By End User, By Region - Industry Forecast 2025-2032
상품코드:1677950
리서치사:SkyQuest
발행일:2025년 03월
페이지 정보:영문 219 Pages
라이선스 & 가격 (부가세 별도)
한글목차
헤파린 세계 시장 규모는 2023년 71억 달러로 평가되며, 2024년 74억 1,000만 달러에서 2032년 103억 7,000만 달러로 성장할 것이며, 예측 기간(2025-2032년) 동안 4.3%의 CAGR로 성장할 것으로 예상됩니다.
세계 헤파린 시장은 주로 심혈관질환의 유병률 증가, 인구 고령화, 외과 수술의 급증에 힘입어 헬스케어 및 제약 분야의 중요한 구성요소로 자리 잡았습니다. 생활습관병의 증가로 인해 항응고제, 특히 이러한 질환의 관리에 필수적인 헤파린에 대한 수요가 증가하고 있습니다. 입원율 증가와 외과적 개입과 같은 요인이 시장 성장을 더욱 촉진하고 있습니다. 그러나 규제 당국의 감시, 시장 경쟁, 헤파린 유발성 혈소판 감소증과 같은 합병증에 따른 위험 등의 문제가 큰 장애물이 되고 있습니다. 그럼에도 불구하고 바이오시밀러 개발, 약물전달 메커니즘의 발전, 신흥국 시장의 성장 등으로 인한 기회로 인해 시장 성장이 기대되고 있습니다.
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.(China)
Faran Shimi Pharmaceutical Company(Iran)
Octapharma AG(Switzerland)
Kamada Ltd.(Israel)
결론과 제안
ksm
영문 목차
영문목차
Global Heparin Market size was valued at USD 7.1 billion in 2023 and is poised to grow from USD 7.41 billion in 2024 to USD 10.37 billion by 2032, growing at a CAGR of 4.3% during the forecast period (2025-2032).
The global heparin market is a critical component of the healthcare and pharmaceutical sectors, driven primarily by the increasing prevalence of cardiovascular diseases, an aging population, and a surge in surgical procedures. The rising incidence of lifestyle-related illnesses is elevating the demand for anticoagulants, particularly heparin, which is essential for managing these conditions. Factors such as higher hospitalization rates and surgical interventions further bolster market growth. However, challenges such as regulatory scrutiny, market competition, and risks associated with complications, including heparin-induced thrombocytopenia, pose significant hurdles. Nevertheless, the market is expected to thrive due to opportunities arising from the development of biosimilars, advancements in drug delivery mechanisms, and growth in emerging markets.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Heparin market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Heparin Market Segments Analysis
Global Heparin Market is segmented by Product Type, Mode of Administration, Source, Ingredient, Availability, Treatment, Therapeutics, Strength, Type, Container, Packaging, Distribution Channel, Application, End User and region. Based on Product Type, the market is segmented into Unfractionated Heparin, Low Molecular Weight Heparin (LMWH) and Ultra-Low Molecular Weight Heparin (ULMWH). Based on Mode of Administration, the market is segmented into Oral Administration and Parenteral Administration. Based on Source, the market is segmented into Bovine and Porcine. Based on Ingredient, the market is segmented into Sodium, Calcium and Others. Based on Availability, the market is segmented into Raw and Processed. Based on Treatment, the market is segmented into Deep Vein Thrombosis, Pulmonary Embolism, Arterial Thromboembolism and Others. Based on Therapeutics, the market is segmented into Cardiovascular, Respiratory, Oncology, Nephrology, CNS and Others. Based on Strength, the market is segmented into 10 -1000 Unit, 1000 -5000 Unit, 5000- 25000 Unit and Others. Based on Type, the market is segmented into Generics and Brands. Based on Container, the market is segmented into Bottles, Bags, Vials and Others. Based on Packaging, the market is segmented into Glass and Plastic. Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Retail Pharmacy and Drug Store, Online Pharmacy and Others. Based on Application, the market is segmented into Pre-Surgical Procedures, Post-Surgical Procedures, Kidney Dialysis, Diagnostic Tests and Others. Based on End User, the market is segmented into Hospitals, Clinics, Homecare, Ambulatory Surgical Centres and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Heparin Market
The global heparin market is primarily driven by the prevalence of cardiovascular diseases, which remain a leading cause of death and illness worldwide. Conditions such as heart attacks, atrial fibrillation, and strokes significantly heighten the risk of thromboembolic complications, thereby boosting the need for anticoagulants like heparin. Additionally, the rising incidence of pulmonary embolism (PE) and deep vein thrombosis (DVT) further fuels the demand for heparin, as it is widely recognized as the standard treatment for these conditions. As a result, the growing focus on cardiovascular health and related disorders continues to propel the heparin market forward.
Restraints in the Global Heparin Market
The global heparin market faces significant restraints primarily due to the severe side effects associated with heparin therapy, particularly the risk of bleeding, which can lead to patient hesitance and concerns among healthcare providers regarding its use. Additionally, conditions such as Heparin-Induced Thrombocytopenia (HIT) can result in serious complications, thereby undermining the confidence in and safety of heparin treatment. Furthermore, the requirement for continuous monitoring of activated partial thromboplastin time (aPTT) with unfractionated heparin to prevent adverse effects and ensure therapeutic efficacy complicates treatment regimens, particularly in outpatient settings, thereby limiting its wide-scale adoption.
Market Trends of the Global Heparin Market
The global heparin market is experiencing a significant shift with a heavy focus on biosimilars, driven by the expiry of patents for original heparin products. This trend is particularly pronounced in Europe and North America, where healthcare providers seek cost-effective alternatives that maintain safety and efficacy. The rise in biosimilars allows for reduced treatment costs, further enhancing patient access to necessary anticoagulant therapies. As regulatory bodies continue to streamline the approval process for these biosimilars, the heparin market is poised for substantial growth, reflecting a broader move towards cost-efficient healthcare solutions while prioritizing patient outcomes.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technological Advancement
Global Heparin Market Size by Product Type & CAGR (2025-2032)
Market Overview
Unfractionated Heparin
Low Molecular Weight Heparin (LMWH)
Ultra-Low Molecular Weight Heparin (ULMWH)
Global Heparin Market Size by Mode of Administration & CAGR (2025-2032)
Market Overview
Oral Administration
Parenteral Administration
Global Heparin Market Size by Source & CAGR (2025-2032)
Market Overview
Bovine
Porcine
Global Heparin Market Size by Ingredient & CAGR (2025-2032)
Market Overview
Sodium
Calcium
Others
Global Heparin Market Size by Availability & CAGR (2025-2032)
Market Overview
Raw
Processed
Global Heparin Market Size by Treatment & CAGR (2025-2032)
Market Overview
Deep Vein Thrombosis
Pulmonary Embolism
Arterial Thromboembolism
Others
Global Heparin Market Size by Therapeutics & CAGR (2025-2032)
Market Overview
Cardiovascular
Respiratory
Oncology
Nephrology
CNS
Others
Global Heparin Market Size by Strength & CAGR (2025-2032)
Market Overview
10 -1000 Unit
1000 -5000 Unit
5000- 25000 Unit
Others
Global Heparin Market Size by Type & CAGR (2025-2032)
Market Overview
Generics
Brands
Global Heparin Market Size by Container & CAGR (2025-2032)
Market Overview
Bottles
Bags
Vials
Others
Global Heparin Market Size by Packaging & CAGR (2025-2032)
Market Overview
Glass
Plastic
Global Heparin Market Size by Distribution Channel & CAGR (2025-2032)
Market Overview
Hospital Pharmacy
Retail Pharmacy and Drug Store
Online Pharmacy
Others
Global Heparin Market Size by Application & CAGR (2025-2032)
Market Overview
Pre-Surgical Procedures
Post-Surgical Procedures
Kidney Dialysis
Diagnostic Tests
Others
Global Heparin Market Size by End User & CAGR (2025-2032)
Market Overview
Hospitals
Clinics
Homecare
Ambulatory Surgical Centres
Others
Global Heparin Market Size & CAGR (2025-2032)
North America (Product Type, Mode of Administration, Source, Ingredient, Availability, Treatment, Therapeutics, Strength, Type, Container, Packaging, Distribution Channel, Application, End User)
US
Canada
Europe (Product Type, Mode of Administration, Source, Ingredient, Availability, Treatment, Therapeutics, Strength, Type, Container, Packaging, Distribution Channel, Application, End User)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Product Type, Mode of Administration, Source, Ingredient, Availability, Treatment, Therapeutics, Strength, Type, Container, Packaging, Distribution Channel, Application, End User)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Product Type, Mode of Administration, Source, Ingredient, Availability, Treatment, Therapeutics, Strength, Type, Container, Packaging, Distribution Channel, Application, End User)
Brazil
Rest of Latin America
Middle East & Africa (Product Type, Mode of Administration, Source, Ingredient, Availability, Treatment, Therapeutics, Strength, Type, Container, Packaging, Distribution Channel, Application, End User)
